CoChat

Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem Correlates

Open access
Dugger, Brittany N., Clark, Christopher M., Serrano, Geidy, Mariner, Monica, Bedell, Barry J., Coleman, R. Edward, Doraiswamy, P. Murali, Lu, Ming, Fleisher, Adam S., Reiman, Eric M., Sabbagh, Marwan N., Sadowsky, Carl H., Schneider, Julie A., Zehntner, Simone P., Carpenter, Alan P., Joshi, Abhinay D., Mintun, Mark A., Pontecorvo, Michael J., Skovronsky, Daniel M., Sue, Lucia I., Beach, Thomas G. · 2014 · Journal of Neuropathology & Experimental Neurology
Cited by 38

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Neuropathologic heterogeneity is often present among Alzheimer disease (AD) patients. We sought to determine whether amyloid imaging measures of AD are affected by concurrent pathologies. Thirty-eight clinically and pathologically defined AD and 17 nondemented patients with quantitative florbetapir F-18 (F-AV-45) positron emission tomography (PET) imaging during life and postmortem histological β-amyloid quantification and neuropathologic examination were assessed. AD patients were divided on the basis of concurrent pathologies, including those with Lewy bodies (LBs) (n = 21), white matter rarefaction (n = 27), severe cerebral amyloid angiopathy (n = 11), argyrophilic grains (n = 5), and TAR DNA binding protein-43 inclusions (n = 18). Many patients exhibited more than 1 type of concurrent pathology. The ratio of cortical to cerebellar amyloid imaging signal (SUVr) and immunohistochemical β-amyloid load were analyzed in 6 cortical regions of interest. All AD subgroups had strong and significant correlations between SUVr and histological β-amyloid measures (p μ 0.001). All AD subgroups had significantly greater amyloid measures versus nondemented patients, and mean amyloid measures did not significantly differ between AD subgroups. When comparing AD cases with and without each pathology, AD cases with LBs had significantly lower SUVr measures versus AD cases without LBs (p = 0.002); there were no other paired comparison differences. These findings indicate that florbetapir-PET imaging is not confounded by neuropathological heterogeneity within AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/nen.0000000000000028

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 38

Metadata

Authors
Dugger, B. N., Clark, C. M., Serrano, G., Mariner, M., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Lu, M., Fleisher, A. S., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., Schneider, J. A., Zehntner, S. P., Carpenter, A. P., Joshi, A. D., Mintun, M. A., Pontecorvo, M. J., Skovronsky, D. M., Sue, L. I., & Beach, T. G.
Venue
Journal of Neuropathology & Experimental Neurology
Published
2014-01
Volume
73
Issue
1
Pages
72-80
ISSN
0022-3069 (ISSN-L)
OpenAlex
W2000064323
Cited by
38
References
15
FWCI
3.19
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem Correlates. https://app.cochat.ai/papers/10.1097/nen.0000000000000028
The paper
Dugger, B. N., Clark, C. M., Serrano, G., Mariner, M., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Lu, M., Fleisher, A. S., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., Schneider, J. A., Zehntner, S. P., Carpenter, A. P., Joshi, A. D., Mintun, M. A., Pontecorvo, M. J., Skovronsky, D. M., . . . Beach, T. G. (2014). Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem Correlates. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1097/nen.0000000000000028

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.